Strata Critical Medical Inc Revenue Growth Rates (SRTA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Strata Critical Medical Inc   (NASDAQ: SRTA)
 

SRTA's Revenue Growth by Quarter and Year

Strata Critical Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SRTA/growth
https://api.csimarket.com/api/v1/companies/SRTA/fundamentals
https://api.csimarket.com/api/v1/companies/SRTA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
SRTA Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 74.08
2nd Quarter June 72.51
1st Quarter March 67.12
FY 213.71

SRTAs Annual Revenue
Strata Critical Medical Inc 's Revenue in the fiscal year 2025 $ 197.13 millions
Strata Critical Medical Inc 's Revenue in the fiscal year 2024 $ 248.69 millions
Strata Critical Medical Inc 's Revenue in the fiscal year 2023 $ 225.18 millions
Strata Critical Medical Inc 's Revenue in the fiscal year 2022 $ 146.12 millions
Strata Critical Medical Inc 's Revenue in the fiscal year 2021 $ 50.53 millions




SRTA Revenue third quarter 2026 Y/Y Growth Comment
Strata Critical Medical Inc achieved in the third quarter 2026, above Company average Revenue rise of 50.27% year on year, to $ 74.08 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 130 other companies have achieved higher Revenue growth. While Strata Critical Medical Inc ' s Revenue jump of 50.27% ranks overall at the positon no. 2480 in the third quarter 2026.


SRTA Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 50.27 %
2nd Quarter June 2.42 %
1st Quarter March 23.59 %
FY   -

Financial Statements
Strata Critical Medical Inc 's third quarter 2026 Revenue $ 74.08 millions SRTA's Income Statement
Strata Critical Medical Inc 's third quarter 2025 Revenue $ 49.30 millions Quarterly SRTA's Income Statement


SRTA Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 2.17 %
2nd Quarter June 8.03 %
1st Quarter March 195.42 %
FY (Year on Year)   -


Back to SRTA Growth rate Comparisons >> Back to SRTA Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #131
Healthcare Sector #362
Overall #2480

Revenue Y/Y Growth Statistics
High Average Low
95.62 % 27.78 % -20.74 %
(Sep 30 2022)   (Dec 31 2025)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #131
Healthcare Sector #362
Overall #2480
Revenue Y/Y Growth Statistics
High Average Low
95.62 % 27.78 % -20.74 %
(Sep 30 2022)   (Dec 31 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Strata Critical Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
195.4 % 16.29 % -100 %
(Mar 31 2026)  


SRTA's III. Quarter Q/Q Revenue Comment
Strata Critical Medical Inc achieved in the III. Quarter 2026 below company average Revenue growth of 2.17% quarter on quarter, to $ 74.08 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -30.37% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Revenue quarter on quarter growth. While Strata Critical Medical Inc 's Revenue growth quarter on quarter, overall rank is 914.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #140
Overall #914
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #140
Overall #914
Revenue Q/Q Growth Statistics
High Average Low
195.4 % 16.29 % -100 %
(Mar 31 2026)  


SRTA's III. Quarter Q/Q Revenue Comment
Strata Critical Medical Inc achieved in the III. Quarter 2026 below company average Revenue growth of 2.17% quarter on quarter, to $ 74.08 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -30.37% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Revenue quarter on quarter growth. While Strata Critical Medical Inc 's Revenue growth quarter on quarter, overall rank is 914.


Strata Critical Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 236.43
Y / Y Revenue Growth (TTM) 3.35 %
Year on Year Revenue Growth Overall Ranking # 1855
Seqeuential Revenue Change (TTM) 11.71 %
Seq. Revenue Growth (TTM) Overall Ranking # 2480


Cumulative Revenue growth Comment
Although Strata Critical Medical Inc 's Annual Revenue growth year on year were below company's average 27.78% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3.35% year on year, from -16.79% in Jun 30 2026.

In the Healthcare sector 290 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1305 to 1855.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 131
Healthcare Sector # 291
Overall # 1855

Revenue TTM Y/Y Growth Statistics
High Average Low
95.62 %
 27.78 %
-20.74 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 131
Sector # 362
S&P 500 # 2480
Cumulative Revenue growth Comment
Although Strata Critical Medical Inc 's Annual Revenue growth year on year were below company's average 27.78% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3.35% year on year, from -16.79% in Jun 30 2026.

In the Healthcare sector 290 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1305 to 1855.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 131
Healthcare Sector # 291
Overall # 1855

Revenue TTM Y/Y Growth Statistics
High Average Low
95.62 %
27.78 %
-20.74 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 131
Sector # 362
S&P 500 # 2480




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SRTA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Profound Medical Corp 85.86%$ 85.857 millions
Vivosim Labs Inc 82.14%$ 82.143 millions
Syndax Pharmaceuticals Inc 81.59%$ 81.592 millions
Nuo Therapeutics Inc 80.81%$ 80.809 millions
Iovance Biotherapeutics inc 80.07%$ 80.074 millions
Rhythm Pharmaceuticals Inc 79.59%$ 79.594 millions
Omniab Inc 78.34%$ 78.339 millions
Aclarion Inc 78.09%$ 78.086 millions
Personalis Inc 76.59%$ 76.585 millions
Delcath Systems Inc 76.05%$ 76.047 millions
Mobia Medical Inc 73.28%$ 73.280 millions
Wave Life Sciences Ltd 72.95%$ 72.950 millions
Igc Pharma Inc 71.73%$ 71.728 millions
Phathom Pharmaceuticals Inc 71.14%$ 71.142 millions
Ptc Therapeutics inc 69.57%$ 69.571 millions
Seres Therapeutics Inc 68.95%$ 68.946 millions
Alamar Biosciences Inc 68.46%$ 68.458 millions
Carlsmed Inc 66.74%$ 66.736 millions
Corcept Therapeutics Inc63.97%$ 63.974 millions
Tarsus Pharmaceuticals Inc 63.92%$ 63.921 millions
Tg Therapeutics Inc 60.74%$ 60.743 millions
Therapeuticsmd Inc 60.59%$ 60.587 millions
Heartflow Inc 60.42%$ 60.425 millions
Glaukos Corp59.02%$ 59.021 millions
X4 Pharmaceuticals Inc58.64%$ 58.640 millions
Kiniksa Pharmaceuticals International Plc58.12%$ 58.121 millions
Envoy Medical Inc 57.14%$ 57.143 millions
Humacyte Inc 55.21%$ 55.208 millions
Butterfly Network Inc 53.45%$ 53.453 millions
Avita Medical Inc 53.05%$ 53.054 millions


About Strata Critical Medical Inc Revenue Growth Rates (SRTA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Strata Critical Medical Inc (CIK 1779128).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-069265
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Strata Critical Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.